Cargando…
Clinical Impact of Vitamin K Dosing on Sorafenib Treatment for Hepatocellular Carcinoma
Background: Some researchers have suggested that vitamin K enhances the antitumor effect of sorafenib for hepatocellular carcinoma (HCC) in vitro and in vivo. In this study, we examined the clinical impact of vitamin K dosing for sorafenib treatment. Methods: Twenty-nine out of 65 patients treated w...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Ivyspring International Publisher
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5559959/ https://www.ncbi.nlm.nih.gov/pubmed/28819398 http://dx.doi.org/10.7150/jca.18900 |